Short communication · 2016
Short communicationPublished 14 Feb 2017
Joint Mean-Variance Overall Survival Time fitted Models from Stage III Non-Small Cell Lung Cancer
1Department of Statistics, The University of Burdwan, Burdwan, West Bengal, India; 2Department of Mathematics, NSHM Knowledge Campus, Durgapur, West Bengal, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives: The current article aims to derive the joint mean-variance fitted models for the overall survival time from stage III non-small cell lung cancer patients. In addition, it aims to identify the determinants of the overall survival time, based on 239 subjects with 23 factors / variables. Background: Overall survival time is positive, heterogeneous, and non-normal which is generally modeled either by the Log-normal or the gamma models. Little is known about the joint mean-variance models for overall survival time from stage III non-small cell lung cancer patients. Materials and Methods: The present article is based on the secondary data on 239 stage III non-small cell lung cancer patients along with 23 explanatory factors/ variables. The overall survival time of 239 patients is heterogeneous, positive, and gamma distributed. Therefore, statistical joint generalized linear gamma or Log-normal models are considered to analyze the overall survival time. Results: The overall survival time (OST) of stage III non-small cell lung cancer (NSCLC) patients is higher for the never/ex-smokers (P =0.049) than for the current smokers. The OST is higher for the stage III NSCLC patients having large cell carcinoma or other (P =0.110) than the patients having adenocarcinoma or squamous cell carcinoma. It decreases (P=0.026) as the number of positive lymph node stations increases. It is higher (P=0.072) of the lung cancer patients having N-stage at level N3 or Nx than the others. It is also higher of the lung cancer patients belonging into standard concomitant (P=0.050), or standard sequential (P=0.026), or sequentialselected (P=0.003) group than the no chemo group. The OST is higher (P<0.01) of those lung cancer patients whose start of the study year are earlier. It increases (P = 0.001) as the equivalent dose increases. It decreases (P<0.01) as the overall treatment time increases. There are many more significant determinants of the variance of OST. Conclusions: The overall survival time from stage III non-small cell lung cancer patients is identified as heterogeneous and gamma distributed. Most of the present findings, specially the variance determinants of overall survival time are completely new in the literature.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 15 Apr 2017
High miRNA-221 expression is associated with poor overall survival in patients with non-small cell lung cancer
Conference abstract · 15 Sep 2014
Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small cell lung cancer progression and patients overall survival
Research article · 23 Sep 2016
Role of GSTM1, GSTT1, and GSTP1 IIe105Val gene polymorphisms in the response to chemotherapy and overall survival of advanced non-small cell lung cancer
Short communication · 29 Jul 2021
Lobectomy versus Stereotactic Ablative Radiotherapy for Medically Operable Patients with Stage IA Non-Small Cell Lung Cancer: A Virtual Randomized Phase III Trial Stratified by Age
More from this journal
The newest in Epidemiology: Open Access.
Review article · 24 Apr 2025
A Review on Diabetic Neuropathy
Rapid communication · 29 Mar 2025
The Role of Behavioral Epidemiology in Shaping Public Health Policy and Interventions
Rapid communication · 29 Mar 2025
The Global Fight against Tuberculosis: Current Trends in Epidemiology and Disease Control
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalEpidemiology: Open Access
- SubjectInfectious Diseases
- SubjectPublic Health & Epidemiology
- BylineArticles whose byline prints “Rabindra Nath Das”
- BylineArticles whose byline prints “Sabyasachi Mukherjee”
